RGPD1/2/3/4/5/8 Blocking Peptide

RANBP2L6; RGP1; RANBP2-like and GRIP domain-containing protein 1; Ran-binding protein 2-like 6; RanBP2-like 6; RanBP2L6; RANBP2L2; RGP2; RANBP2-like and GRIP domain-containing protein 2; Ran-binding protein 2-like 2; RanBP2-like 2; RanBP2L2; RGP3; RanBP2-like and GRIP domain-containing protein 3; RGP4; RanBP2-like and GRIP domain-containing protein 4; RANBP2L1; RGP5; RGP7; RGPD7; RANBP2L2; RGP6; RANBP2-like and GRIP domain-containing protein 5/6; Ran-binding protein 2-like 1/2; RanBP2-like 1/2; RanBP2L1; RanBP2L2; Sperm membrane protein BS-63; RANBP2ALPHA; RANBP2L1; RANBP2L3; RANBP2-like and GRIP domain-containing protein 8; Ran-binding protein 2-like 3; RanBP2-like 3; RanBP2L3

Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4°C for overnight or at room temperature for 2 hours.